HC Deb 03 December 1984 vol 69 c75W
Mr. Caborn

asked the Secretary of State for Social Services what evidence is available to him about the risks to women of the injectable contraceptive Depo Provera.

Mr. Kenneth Clarke

Evidence on the possible adverse effects of Depo Provera was considered by a panel of persons appointed to hear an application by Upjohn Ltd. for a product licence to market Depo Provera as a long-term contraceptive. The panel's report was submitted to us in April this year and copies were placed in the Library.